Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Resources | 3 | 2019 | 922 | 0.930 |
Why?
|
| Public Facilities | 1 | 2020 | 35 | 0.790 |
Why?
|
| Hospitals, Public | 1 | 2020 | 203 | 0.710 |
Why?
|
| Infant Mortality | 3 | 2017 | 740 | 0.710 |
Why?
|
| Education, Public Health Professional | 1 | 2018 | 25 | 0.710 |
Why?
|
| Ethiopia | 6 | 2021 | 463 | 0.690 |
Why?
|
| Child Mortality | 3 | 2017 | 192 | 0.680 |
Why?
|
| Financing, Organized | 1 | 2019 | 199 | 0.660 |
Why?
|
| Time and Motion Studies | 1 | 2017 | 154 | 0.620 |
Why?
|
| Delivery of Health Care | 8 | 2018 | 4810 | 0.600 |
Why?
|
| Maternal Mortality | 2 | 2016 | 280 | 0.590 |
Why?
|
| Developing Countries | 9 | 2018 | 2674 | 0.570 |
Why?
|
| Health Care Costs | 2 | 2020 | 3152 | 0.570 |
Why?
|
| International Cooperation | 4 | 2018 | 1434 | 0.540 |
Why?
|
| Primary Health Care | 5 | 2021 | 4485 | 0.530 |
Why?
|
| Health Expenditures | 8 | 2019 | 2240 | 0.520 |
Why?
|
| Financing, Government | 1 | 2018 | 481 | 0.520 |
Why?
|
| Cost of Illness | 3 | 2020 | 1820 | 0.420 |
Why?
|
| Health Services Accessibility | 4 | 2019 | 4988 | 0.380 |
Why?
|
| Leadership | 1 | 2018 | 1325 | 0.360 |
Why?
|
| Proinsulin | 1 | 2009 | 128 | 0.360 |
Why?
|
| Euthyroid Sick Syndromes | 1 | 2008 | 14 | 0.360 |
Why?
|
| Accounting | 2 | 1999 | 23 | 0.350 |
Why?
|
| Health Promotion | 2 | 2017 | 2172 | 0.340 |
Why?
|
| Hypoxanthines | 4 | 1991 | 33 | 0.330 |
Why?
|
| Program Evaluation | 1 | 2016 | 2524 | 0.320 |
Why?
|
| Health Care Sector | 2 | 2007 | 194 | 0.300 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 667 | 0.300 |
Why?
|
| Artemisinins | 3 | 1997 | 216 | 0.290 |
Why?
|
| Sesquiterpenes | 3 | 1997 | 181 | 0.290 |
Why?
|
| Thyroxine | 1 | 2008 | 650 | 0.270 |
Why?
|
| Financing, Personal | 1 | 2007 | 312 | 0.260 |
Why?
|
| National Health Programs | 2 | 1999 | 438 | 0.260 |
Why?
|
| Health Policy | 2 | 2015 | 2615 | 0.250 |
Why?
|
| Xanthine Oxidase | 3 | 1991 | 75 | 0.240 |
Why?
|
| Public Sector | 5 | 2007 | 267 | 0.230 |
Why?
|
| Family Characteristics | 3 | 2017 | 924 | 0.230 |
Why?
|
| India | 2 | 2019 | 1967 | 0.220 |
Why?
|
| Antimalarials | 3 | 1997 | 859 | 0.210 |
Why?
|
| Financial Support | 3 | 2016 | 122 | 0.210 |
Why?
|
| Indonesia | 3 | 2017 | 118 | 0.210 |
Why?
|
| Economic Development | 2 | 2018 | 70 | 0.200 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 2996 | 0.200 |
Why?
|
| Erythrocytes | 4 | 1991 | 2418 | 0.200 |
Why?
|
| Health Care Reform | 2 | 2007 | 1248 | 0.200 |
Why?
|
| Autoantibodies | 1 | 2008 | 1976 | 0.190 |
Why?
|
| Public Assistance | 2 | 2017 | 45 | 0.190 |
Why?
|
| Body Composition | 1 | 2009 | 2393 | 0.180 |
Why?
|
| Family Planning Services | 2 | 2019 | 235 | 0.180 |
Why?
|
| Education, Graduate | 1 | 2018 | 72 | 0.170 |
Why?
|
| Heme | 2 | 1997 | 297 | 0.170 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4293 | 0.170 |
Why?
|
| Time Management | 1 | 2017 | 59 | 0.160 |
Why?
|
| Hemin | 2 | 1996 | 51 | 0.160 |
Why?
|
| Health Services | 2 | 2018 | 732 | 0.160 |
Why?
|
| Private Sector | 4 | 2007 | 390 | 0.150 |
Why?
|
| Prenatal Care | 2 | 2021 | 1005 | 0.150 |
Why?
|
| Socioeconomic Factors | 6 | 2019 | 7644 | 0.150 |
Why?
|
| Membrane Lipids | 1 | 1997 | 253 | 0.140 |
Why?
|
| Program Development | 2 | 2018 | 1328 | 0.140 |
Why?
|
| Dipeptidases | 1 | 2014 | 36 | 0.130 |
Why?
|
| State Medicine | 1 | 2015 | 202 | 0.130 |
Why?
|
| Lubricants | 1 | 2013 | 31 | 0.130 |
Why?
|
| Phosphoribosyl Pyrophosphate | 2 | 1990 | 5 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2020 | 982 | 0.120 |
Why?
|
| Purines | 3 | 1991 | 600 | 0.120 |
Why?
|
| Goals | 1 | 2017 | 642 | 0.120 |
Why?
|
| Health Services Needs and Demand | 2 | 2015 | 1435 | 0.110 |
Why?
|
| Ambulatory Care | 2 | 2004 | 2765 | 0.110 |
Why?
|
| Maternal Health Services | 2 | 2019 | 432 | 0.110 |
Why?
|
| Data Collection | 2 | 1999 | 3276 | 0.110 |
Why?
|
| Humans | 38 | 2021 | 708843 | 0.110 |
Why?
|
| Food Supply | 1 | 2017 | 457 | 0.110 |
Why?
|
| Plasmodium falciparum | 2 | 1991 | 1620 | 0.110 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2010 | 19 | 0.100 |
Why?
|
| South Africa | 3 | 2013 | 1555 | 0.100 |
Why?
|
| Pentosephosphates | 1 | 1990 | 7 | 0.100 |
Why?
|
| Social Planning | 1 | 2010 | 10 | 0.100 |
Why?
|
| Privatization | 3 | 2005 | 43 | 0.100 |
Why?
|
| Child, Preschool | 10 | 2017 | 41081 | 0.090 |
Why?
|
| Social Justice | 2 | 2007 | 420 | 0.090 |
Why?
|
| Organizational Case Studies | 2 | 2007 | 314 | 0.090 |
Why?
|
| Urban Population | 1 | 2017 | 2006 | 0.090 |
Why?
|
| Quality of Health Care | 2 | 2021 | 4266 | 0.080 |
Why?
|
| Public Health | 2 | 2019 | 2363 | 0.080 |
Why?
|
| Hypoxanthine | 3 | 1991 | 29 | 0.080 |
Why?
|
| Infant | 7 | 2017 | 34261 | 0.080 |
Why?
|
| Health Services Research | 3 | 2003 | 1836 | 0.080 |
Why?
|
| Turkey | 1 | 2007 | 230 | 0.080 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 648 | 0.080 |
Why?
|
| Rural Population | 1 | 2017 | 2130 | 0.080 |
Why?
|
| Obesity | 1 | 2009 | 12031 | 0.080 |
Why?
|
| Trace Elements | 1 | 1988 | 199 | 0.080 |
Why?
|
| Child Health Services | 1 | 2012 | 678 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2016 | 1969 | 0.070 |
Why?
|
| Homosexuality, Male | 1 | 2013 | 1133 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2008 | 1004 | 0.070 |
Why?
|
| Subcutaneous Fat | 1 | 2009 | 384 | 0.070 |
Why?
|
| Curriculum | 1 | 2018 | 3329 | 0.070 |
Why?
|
| Boston | 1 | 2018 | 9402 | 0.070 |
Why?
|
| Phosphates | 1 | 1988 | 787 | 0.070 |
Why?
|
| Insurance, Health | 2 | 2015 | 2475 | 0.070 |
Why?
|
| Premenopause | 1 | 2009 | 1009 | 0.070 |
Why?
|
| Private Practice | 1 | 2005 | 155 | 0.070 |
Why?
|
| Insurance, Physician Services | 1 | 2004 | 22 | 0.070 |
Why?
|
| Immunoassay | 1 | 2008 | 766 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2005 | 182 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 1721 | 0.060 |
Why?
|
| Pregnancy | 5 | 2021 | 26832 | 0.060 |
Why?
|
| Homozygote | 1 | 2009 | 1849 | 0.060 |
Why?
|
| Running | 1 | 1988 | 466 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2017 | 24433 | 0.060 |
Why?
|
| Fasting | 1 | 2009 | 1608 | 0.060 |
Why?
|
| Chloroquine | 3 | 1996 | 288 | 0.060 |
Why?
|
| Heterozygote | 1 | 2009 | 2780 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2009 | 3701 | 0.050 |
Why?
|
| Rural Health Services | 1 | 2005 | 369 | 0.050 |
Why?
|
| Oxygen | 2 | 1990 | 4150 | 0.050 |
Why?
|
| Capital Expenditures | 1 | 1999 | 22 | 0.050 |
Why?
|
| Partial Pressure | 2 | 1990 | 261 | 0.050 |
Why?
|
| Nutritional Status | 1 | 1988 | 1532 | 0.050 |
Why?
|
| Vitamins | 1 | 1988 | 1466 | 0.050 |
Why?
|
| Adiposity | 1 | 2009 | 1734 | 0.050 |
Why?
|
| Female | 15 | 2021 | 375205 | 0.040 |
Why?
|
| Superoxide Dismutase | 2 | 1991 | 607 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2003 | 583 | 0.040 |
Why?
|
| Glycine | 2 | 1991 | 693 | 0.040 |
Why?
|
| Thiobarbiturates | 1 | 1997 | 6 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 1997 | 120 | 0.040 |
Why?
|
| Sulfonic Acids | 1 | 1997 | 97 | 0.040 |
Why?
|
| Peroxidases | 1 | 1997 | 145 | 0.040 |
Why?
|
| Spectrophotometry | 1 | 1997 | 376 | 0.040 |
Why?
|
| Classification | 1 | 1997 | 138 | 0.040 |
Why?
|
| Nutrition Disorders | 1 | 2017 | 214 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1996 | 232 | 0.040 |
Why?
|
| Developed Countries | 1 | 1999 | 402 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 1997 | 248 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 1997 | 311 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 1997 | 230 | 0.040 |
Why?
|
| Erythrocyte Membrane | 1 | 1997 | 444 | 0.030 |
Why?
|
| Adult | 8 | 2016 | 211041 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2009 | 6255 | 0.030 |
Why?
|
| Genotype | 1 | 2009 | 12863 | 0.030 |
Why?
|
| World Health Organization | 1 | 2000 | 1261 | 0.030 |
Why?
|
| Insulin | 1 | 2009 | 6648 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1997 | 735 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2013 | 711 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 1991 | 2203 | 0.030 |
Why?
|
| Vitamin E | 1 | 1997 | 842 | 0.030 |
Why?
|
| Hemolysis | 1 | 2014 | 407 | 0.030 |
Why?
|
| Maternal Welfare | 1 | 2012 | 118 | 0.030 |
Why?
|
| Kinetics | 2 | 1991 | 6796 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2000 | 1134 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 2927 | 0.030 |
Why?
|
| Phenotype | 1 | 2009 | 16306 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 2325 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2009 | 21194 | 0.030 |
Why?
|
| Nucleotidases | 1 | 1990 | 31 | 0.030 |
Why?
|
| Purine Nucleotides | 1 | 1990 | 29 | 0.030 |
Why?
|
| Child | 6 | 2021 | 73636 | 0.030 |
Why?
|
| Catalase | 1 | 1991 | 239 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 16008 | 0.020 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2010 | 44 | 0.020 |
Why?
|
| Perinatal Care | 1 | 2012 | 230 | 0.020 |
Why?
|
| Inosine Monophosphate | 1 | 1988 | 7 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1991 | 626 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1997 | 1620 | 0.020 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2010 | 240 | 0.020 |
Why?
|
| Child Welfare | 1 | 2012 | 512 | 0.020 |
Why?
|
| Income | 1 | 2016 | 1775 | 0.020 |
Why?
|
| Iron | 1 | 1996 | 1710 | 0.020 |
Why?
|
| HIV Infections | 1 | 2013 | 15538 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 1988 | 447 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1988 | 661 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3518 | 0.020 |
Why?
|
| Health Transition | 1 | 2005 | 38 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 1633 | 0.020 |
Why?
|
| Adenine | 1 | 1991 | 916 | 0.020 |
Why?
|
| Biological Transport | 1 | 1990 | 2146 | 0.020 |
Why?
|
| Poverty | 1 | 2017 | 2557 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1984 | 129 | 0.020 |
Why?
|
| Poland | 1 | 2004 | 182 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1988 | 2635 | 0.020 |
Why?
|
| Nutritional Sciences | 1 | 1984 | 145 | 0.010 |
Why?
|
| Rural Health | 1 | 1984 | 292 | 0.010 |
Why?
|
| Biopsy | 1 | 2014 | 6766 | 0.010 |
Why?
|
| Taxes | 1 | 2004 | 205 | 0.010 |
Why?
|
| Vietnam | 1 | 2002 | 385 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1984 | 892 | 0.010 |
Why?
|
| Risk | 1 | 2013 | 9641 | 0.010 |
Why?
|
| Forecasting | 1 | 2010 | 2941 | 0.010 |
Why?
|
| Male | 7 | 2017 | 349524 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 23020 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 2005 | 696 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 9488 | 0.010 |
Why?
|
| Reference Values | 1 | 1988 | 5041 | 0.010 |
Why?
|
| China | 1 | 2005 | 2251 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1983 | 555 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 11239 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2004 | 650 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2010 | 1847 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 1979 | 238 | 0.010 |
Why?
|
| Liver | 1 | 2014 | 7622 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 1984 | 1146 | 0.010 |
Why?
|
| Home Care Services | 1 | 2004 | 592 | 0.010 |
Why?
|
| Spectroscopy, Mossbauer | 1 | 1996 | 2 | 0.010 |
Why?
|
| Health Education | 1 | 1984 | 1062 | 0.010 |
Why?
|
| Quinine | 1 | 1996 | 59 | 0.010 |
Why?
|
| Hemeproteins | 1 | 1996 | 67 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1984 | 1156 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1991 | 20170 | 0.010 |
Why?
|
| Models, Biological | 1 | 1990 | 9907 | 0.010 |
Why?
|
| Social Class | 1 | 2002 | 1925 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2004 | 1746 | 0.010 |
Why?
|
| Animals | 4 | 1996 | 170486 | 0.010 |
Why?
|
| Research Design | 1 | 1988 | 5833 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 20320 | 0.010 |
Why?
|
| United States | 1 | 1999 | 67165 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 50597 | 0.010 |
Why?
|
| Diet | 1 | 1988 | 7392 | 0.010 |
Why?
|
| Malaria | 1 | 1996 | 1076 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2014 | 71483 | 0.000 |
Why?
|
| Adolescent | 2 | 2005 | 84718 | 0.000 |
Why?
|
| Time Factors | 1 | 1988 | 41038 | 0.000 |
Why?
|
| Myoglobinuria | 1 | 1983 | 24 | 0.000 |
Why?
|
| Cathepsin D | 1 | 1983 | 66 | 0.000 |
Why?
|
| Hyperbilirubinemia | 1 | 1983 | 71 | 0.000 |
Why?
|
| Amniotic Fluid | 1 | 1984 | 357 | 0.000 |
Why?
|
| Cathepsins | 1 | 1983 | 308 | 0.000 |
Why?
|
| Creatine Kinase | 1 | 1983 | 713 | 0.000 |
Why?
|
| Genetic Counseling | 1 | 1984 | 577 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1979 | 6991 | 0.000 |
Why?
|
| Amikacin | 1 | 1979 | 50 | 0.000 |
Why?
|
| Tobramycin | 1 | 1979 | 73 | 0.000 |
Why?
|
| Middle Aged | 2 | 2005 | 213752 | 0.000 |
Why?
|
| Aminoglycosides | 1 | 1979 | 163 | 0.000 |
Why?
|
| Gentamicins | 1 | 1979 | 262 | 0.000 |
Why?
|
| Muscles | 1 | 1983 | 1622 | 0.000 |
Why?
|
| Aged | 1 | 2002 | 161488 | 0.000 |
Why?
|
| Rats | 1 | 1983 | 25094 | 0.000 |
Why?
|
Concepts
(240)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_